Log in
NASDAQ:ANPC

Anpac Bio-Medical Science Stock Forecast, Price & News

$3.21
-0.15 (-4.47 %)
(As of 10/30/2020 12:00 AM ET)
Add
Compare
Today's Range
$3.18
Now: $3.21
$3.39
50-Day Range
$3.36
MA: $4.00
$5.20
52-Week Range
$3.15
Now: $3.21
$12.18
Volume18,289 shs
Average Volume32,419 shs
Market Capitalization$35.92 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Anpac Bio-Medical Science Co., Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests to corporations and life insurance companies in the People's Republic of China and the United States. It also manufactures cancer differentiation analysis devices; and offers physical checkup package services. The company was founded in 2010 and is headquartered in Lishui, the People's Republic of China.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.71 out of 5 stars

Industry, Sector and Symbol

Industry Medical laboratories
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:ANPC
CUSIPN/A
CIKN/A
Phone86-57-8205-1666
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.56 million
Book Value($1.37) per share

Profitability

Miscellaneous

Market Cap$35.92 million
Next Earnings DateN/A
OptionableNot Optionable
$3.21
-0.15 (-4.47 %)
(As of 10/30/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ANPC News and Ratings via Email

Sign-up to receive the latest news and ratings for ANPC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Anpac Bio-Medical Science (NASDAQ:ANPC) Frequently Asked Questions

How has Anpac Bio-Medical Science's stock been impacted by Coronavirus?

Anpac Bio-Medical Science's stock was trading at $8.50 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, ANPC stock has decreased by 62.3% and is now trading at $3.2075.
View which stocks have been most impacted by COVID-19
.

Who are some of Anpac Bio-Medical Science's key competitors?

What other stocks do shareholders of Anpac Bio-Medical Science own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Anpac Bio-Medical Science investors own include Applied Genetic Technologies (AGTC), Aurora Cannabis (ACB), Adobe (ADBE), Advaxis (ADXS), Aptose Biosciences (APTO), Arcturus Therapeutics (ARCT), Ardelyx (ARDX), Ascendis Pharma A/S (ASND), Athenex (ATNX) and Aurinia Pharmaceuticals (AUPH).

When did Anpac Bio-Medical Science IPO?

(ANPC) raised $22 million in an initial public offering on the week of January 13th 2020. The company issued 1,700,000 shares at a price of $12.00-$14.00 per share. WestPark Capital and Univest Securities served as the underwriters for the IPO.

What is Anpac Bio-Medical Science's stock symbol?

Anpac Bio-Medical Science trades on the NASDAQ under the ticker symbol "ANPC."

How do I buy shares of Anpac Bio-Medical Science?

Shares of ANPC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Anpac Bio-Medical Science's stock price today?

One share of ANPC stock can currently be purchased for approximately $3.21.

How big of a company is Anpac Bio-Medical Science?

Anpac Bio-Medical Science has a market capitalization of $35.92 million and generates $1.56 million in revenue each year. The company earns $-14,520,000.00 in net income (profit) each year or ($1.62) on an earnings per share basis.

What is Anpac Bio-Medical Science's official website?

The official website for Anpac Bio-Medical Science is www.anpacbio.com.

How can I contact Anpac Bio-Medical Science?

Anpac Bio-Medical Science's mailing address is 801 BIXING STREET BIHU COUNTY ZHEJIANG PROVINCE, LISHUI F4, 323006. The company can be reached via phone at 86-57-8205-1666 or via email at [email protected]

This page was last updated on 10/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.